Centro Ricerca Tettamanti Pediatrics University of Milano Bicocca Monza Italy

Children's Cancer Research Institute Vienna Austria

CLIP Department of Paediatric Haematology Oncology 2nd Faculty of Medicine of Charles University Prague and University Hospital Motol Prague Czech Republic

Department of Advanced Diagnosis Clinical Research Center National Hospital Organization Nagoya Medical Center Nagoya Japan

Department of Clinical Sciences Pediatrics Umeå University Umeå Sweden

Department of Genetics Robert Debré Hospital and Université Paris Cité Paris France

Department of Oncology St Jude Children's Research Hospital Memphis TN USA

Department of Pathology St Jude Children's Research Hospital Memphis TN USA

Department of Pediatric Hematology and Oncology Research National Research Institute for Child Health and Development Tokyo Japan

Department of Pediatrics Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center University of California San Francisco San Francisco CA USA

Department of Pediatrics Christian Albrechts University Kiel and University Medical Center Schleswig Holstein Kiel Germany

Department of Pediatrics Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Department of Pediatrics Hokkaido University Graduate School of Medicine Sapporo Japan

Division of Hematology Oncology Chang Gung Memorial Hospital at Linkou and Chang Gung University Taoyuan Taiwan

Hannover Medical School Institute of Human Genetics Hannover Germany

Khoo Teck Puat National University Children's Medical Institute Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Leukaemia Research Cytogenetics Group Wolfson Childhood Cancer Research Centre Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

Medical Genetics School of Medicine and Surgery University of Milano Bicocca Monza Italy

Oncode Institute Utrecht The Netherlands

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

Zobrazit více v PubMed

Moorman AV, Antony G, Wade R, Butler ER, Enshaei A, Harrison CJ, et al. Time to cure for childhood and young adult acute lymphoblastic leukemia is independent of early risk factors: long-term follow-up of the UKALL2003 trial. J Clin Oncol. 2022;JCO2200245. 10.1200/JCO.22.00245. Online ahead of print. PubMed

Moorman AV, Schwab C, Winterman E, Hancock J, Castleton A, Cummins M, et al. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion. Br J Haematol. 2020;191:844–51. doi: 10.1111/bjh.17093. PubMed DOI

Suzuki K, Okuno Y, Kawashima N, Muramatsu H, Okuno T, Wang X, et al. MEF2D-BCL9 fusion gene is associated with high-risk acute B-cell precursor lymphoblastic leukemia in adolescents. J Clin Oncol. 2016;34:3451–9. doi: 10.1200/JCO.2016.66.5547. PubMed DOI

Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173–83. doi: 10.1016/j.ebiom.2016.04.038. PubMed DOI PMC

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat Genet. 2016;48:569–74. doi: 10.1038/ng.3535. PubMed DOI

Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, et al. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. Nat Commun. 2016;7:13331. doi: 10.1038/ncomms13331. PubMed DOI PMC

Ohki K, Kiyokawa N, Saito Y, Hirabayashi S, Nakabayashi K, Ichikawa H, et al. Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion. Haematologica. 2019;104:128–37. doi: 10.3324/haematol.2017.186320. PubMed DOI PMC

Zaliova M, Stuchly J, Winkowska L, Musilova A, Fiser K, Slamova M, et al. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104:1396–406. doi: 10.3324/haematol.2018.204974. PubMed DOI PMC

Hirabayashi S, Butler ER, Ohki K, Kiyokawa N, Bergmann AK, Möricke A, et al. Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group. Leukemia. 2021;35:3272–7. doi: 10.1038/s41375-021-01199-0. PubMed DOI PMC

Lee SHR, Antillon-Klussmann F, Pei D, Yang W, Roberts KG, Li Z, et al. Association of genetic ancestry with the molecular subtypes and prognosis of childhood acute lymphoblastic leukemia. JAMA Oncol. 2022;8:354–63. doi: 10.1001/jamaoncol.2021.6826. PubMed DOI PMC

Moorman AV, Enshaei A, Schwab C, Wade R, Chilton L, Elliott A, et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. Blood. 2014;124:1434–44. doi: 10.1182/blood-2014-03-562918. PubMed DOI